AI assistant
METLIFE INC — Director's Dealing 2024
Feb 29, 2024
29995_dirs_2024-02-29_bcfe66ed-c1a5-4ea8-abe0-5527bf2cc03c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2024-02-27
Reporting Person: McCallion John D. (EVP & Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-27 | Common Stock | A | 10845 | — | Acquired | 172643 | Direct |
| 2024-02-27 | Common Stock | A | 71915 | — | Acquired | 244558 | Direct |
| 2024-02-27 | Common Stock | F | 34613 | $69.16 | Disposed | 209945 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-27 | Employee Stock Options (right to buy) | $69.16 | A | 32538 | Acquired | 2034-02-26 | Common Stock (32538) | Direct |
Footnotes
F1: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F2: Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F3: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
F4: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.